Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-009791
Filing Date
2013-02-19
Accepted
2013-02-19 17:06:54
Documents
1
Period of Report
2013-02-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3729
  Complete submission text file 0001209191-13-009791.txt   5267
Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Issuer) CIK: 0000858803 (see all company filings)

EIN.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 DUPONT DRIVE IRVINE CA 92612
Business Address
Whitcup Scott M (Reporting) CIK: 0001298941 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15803 | Film No.: 13624193